Statins and myocardial infarction: Type, dose, and administration time: Does it matter?

Area of Science:

• Cardiology
• Pharmacology

Background:

• ST-elevation myocardial infarction (STEMI) patients represent a high-risk group requiring optimized treatment strategies.
• Statins are fundamental in managing coronary artery disease (CAD) due to their lipid-lowering and pleiotropic effects.

Purpose of the Study:

• To highlight the importance of statins in STEMI patient care.
• To identify areas requiring further investigation regarding statin therapy in STEMI.

Main Methods:

• Review of current clinical and experimental knowledge on statin use in CAD and STEMI.
• Identification of unresolved questions in statin therapy for STEMI patients.

Main Results:

• Statins offer significant benefits beyond lipid reduction in CAD patients.
• Pleiotropic effects of statins are particularly relevant for vulnerable STEMI populations.

Conclusions:

• Statins are indispensable for STEMI management, complementing their role in CAD prevention.
• Optimal statin selection, dosage, administration timing, and treatment duration for STEMI patients warrant further research and clinical discussion.